
10,000+ employees
💰 Post-IPO Debt on 2021-02
Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.
🕒 May 20
10,000+ employees
Business Development Director managing existing and new Beauty accounts across EMEA for Catalent. Driving commercial proposals and managing customer relationships in the Beauty sector.